The effect of Esomeprazole to asthma control in asthma patients with GERD taking inhaled corticosteroid
Not Applicable
Recruiting
- Conditions
- Bronchial asthma with gastroesophageal reflux disease(GERD)
- Registration Number
- JPRN-UMIN000011811
- Lead Sponsor
- Department of Hematology and Respiratory Medicine in Kochi University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
(1)hypersensitivity to EPZ or other PPI (2)treated with atazanavir sulfate (3)hypersensitivity to drugs (4)severe disease in liver, kidney, heart (5)severe symptom in gastrointestinal tract(hematemesis, hemorrhagic stool, severe anemia, sudden weight loss) (6)past history of gastrointestinal tract resection, vagotomy, lung resection (7)in combination with other PPI or histamine H2 antagonist (8)not treated with systemic steroid for 3 months before the enrollment (9)decided to be unsuitable to enrollment by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of %FEV1 12 weeks after the introduction of EPZ.
- Secondary Outcome Measures
Name Time Method